BOT 0.00% 38.0¢ botanix pharmaceuticals ltd

Ann: FDA Clears Development Path for BTX 1801, page-62

  1. 809 Posts.
    lightbulb Created with Sketch. 476
    That’s my understanding, though I’m not sure why they haven’t applied for fast track already. Perhaps they wanted an agreed trial plan first to accompany the application.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.